Novavax, J&J Vaccine Candidates Effective Against COVID-19, Variants
Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.
Oral CGRP Inhibitor Rimegepant Effective in Migraine Prevention, Study Finds
In a phase 2/3 study, nearly half of rimegepant-treated patients demonstrated ≥50% reduction in the number of moderate-to-severe migraine days per month
COVID-19: Levels are Decreasing, but CDC Urges Public to Remain Cautious
US levels of SARS-CoV-2 circulation, associated illnesses, and deaths have been decreasing, but rising reporting delays due to holidays warrant caution.
FDA Approves Novel Agent for Treatment of Heart Failure
The FDA approved vericiguat to reduce the risk of CV death and rehospitalization for HF in HF patients after hospital discharge or after outpatient treatment with IV diuretics.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 28, 2021
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
Primary Viewpoints Episode 6: COVID-19 Impact on Physician Mental Health
In episode 6 of Primary Viewpoints, physician mental health expert Michael Myers, MD, discusses the state of physician mental health during the COVID-19 pandemic.
Physician Mental Health Expert: Please, Check In with Each Other
The COVID-19 pandemic, says Dr Michael Myers, is an unprecedented environment for practicing medicine and for practitioners to effectively process daily experience.
COVID-19 Vaccine: US Cities in Greatest Immediate Need
Availability of the COVID-19 vaccine cannot come fast enough for many large US cities, based on the share in each of the most vulnerable populations.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 27, 2021
Global confirmed cases of COVID-19 have surpassed 100 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Study: Metabolic Surgery May be Cure for Type 2 Diabetes
Compared to medication and lifestyle changes, metabolic surgery is more effective in the long-term control of severe T2D, a new study found.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 26, 2021
Exercise Insufficient to Overcome CVD Risks of Overweight/Obesity
Physical activity cannot compensate adequately for the negative impact of excess body weight on cardiometabolic health.
Merck Says it Will Stop Development of COVID-19 Vaccine Candidates
Merck announced today that it will halt development of its COVID-19 vaccine candidates, citing inadequate immune responses to the vaccines.
FDA Approval Granted for First Long-acting Injectable HIV Therapy
Cabotegravir and rilpivirine, injectable formulation is administered once-weekly, reducing treatment days for adults with HIV from 365 to 12.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 25, 2021
US confirmed cases of COVID-19 have surpassed 25 million; global cases have reached 99 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Seen in the ED: Fever, Joint Pain, and Positive Jolt Sign in a Young Man
Fever is up to 103.5°F, joint pain is affecting lower extremities, bilaterally, and the patient complains of headache. Could sex have anything to do with it?
FDA Update: Blood Donation During COVID-19 Pandemic
The FDA provides details on how COVID-19 infection or vaccination against the virus affects a waiting period to donate. Please share the information with your patients.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 22, 2021
Global confirmed cases of COVID-19 have surpassed 97 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
7 Myths and Facts about the COVID-19 Vaccines for PCPs and Patients
Patients trust primary care providers for accurate information on the COVID-19 vaccines. Here are 7 of the many myths now widespread you may need to explain to your patients.
Pfizer-BioNTech COVID-19 Vaccine Found Effective Against UK Variant
Results from a new study confirm that the Pfizer-BioNTech COVID-19 vaccine works against the fast-spreading UK variant of SARS-CoV-2.